Northwire Canada EditionSaturday, July 18, 2026
Northwire
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%
Earnings

NEUPATH HEALTH TO REPORT Q3 RESULTS AND HOST INVESTOR WEBINAR

NPTH · Price

Executive Summary

  • NeuPath Health Inc. will publish its Q3 2025 financial results on Thursday, November 13 2025 before the market opens.
  • A live webcast with CEO Joe Walewicz will be held at 10:00 AM ET (7:00 AM PT) to discuss the results, operations and outlook.
  • The announcement includes standard forward‑looking disclaimer language but no new financial or operational metrics.

Key Details

  • Release Timing: Q3 2025 results to be released before market open on 13 Nov 2025.
  • Webcast Information: Presentation and Q&A webinar hosted by Martin Gagel (Radius Research) at 10:00 AM ET / 7:00 AM PT; registration link provided.
  • Speaker: Joe Walewicz, Chief Executive Officer of NeuPath Health Inc.
  • Contact for Inquiries: Jeff Zygouras, CFO – [email protected], (905) 858‑1368.

Notable Quotes

(No direct quotes were included in the release.)

Read the original news release →

More from Neupath Health Inc.